Multitarget Stool DNA Test Has Higher Sensitivity for CRC Than FIT

THURSDAY, March 14, 2024-- A next-generation multitarget stool DNA test has higher sensitivity for colorectal cancer and advanced precancerous lesions than fecal immunochemical testing (FIT), according to a study published in the March 14 issue of...